HIV researcher describes 'Orwellian' pressure as Trump officials reshape NIH grant decisions

Dr Jade Pagkas-Bather says she was forced to abandon a National Institutes of Health-funded trial testing $500 monthly cash payments to help poor, HIV-positive young people in Chicago adhere to treatment after NIH began re-evaluating grants not in 'alignment' with administration priorities. Researchers warn the moves signal political interference in scientific funding.

Dr Jade Pagkas-Bather received her first National Institutes of Health grant in June 2025 and planned a randomized controlled trial to test whether monthly payments of $500 would help poor, HIV-positive young people in Chicago remain engaged in treatment. The simple but contentious premise — that direct cash assistance could improve adherence and health outcomes — was central to a study aimed at addressing disparities among a vulnerable population.

Her project, and others like it, have been disrupted as NIH officials re-examine awards they deem not in 'alignment' with administration priorities. Researchers say they have been forced to alter or even scrap original study designs after guidance from agency officials signalled a new level of political scrutiny over which projects receive support.

Scientists affected by the reviews described the process as 'Orwellian', saying it represents a departure from long-standing norms intended to insulate peer-reviewed science from short-term political considerations. The intervention has prompted concern across parts of the research community that investigations into social and structural drivers of health — including poverty, housing and economic interventions — may face heightened obstacles at the funding stage.

The changes have practical implications for populations the studies aimed to help. Trials like Pagkas-Bather's sought to generate rigorous evidence on policy-relevant interventions that could be deployed to improve care for people living with HIV. Researchers warn that delaying or reshaping such work could slow progress on interventions targeted at marginalized groups and create a chilling effect on proposals that touch on politically sensitive subjects.

Advocates and scientists are calling for clarity about the criteria being used to reassess grants and for protections to preserve scientific independence in funding decisions. The dispute underscores tensions between an administration intent on steering federal priorities and a research community that says methodological merit and public health need should determine the course of study funding.

As investigators adapt to the new terrain, some are revising research plans to meet the revised expectations, while others say they will seek alternative funding or postpone work. The episode highlights broader questions about how political oversight of federal agencies can reshape the research agenda and influence which questions are pursued in the name of public health.